elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38241714-182AAEB4-EE18-48B9-8D18-F3877F23E232
Q38241714-182AAEB4-EE18-48B9-8D18-F3877F23E232
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38241714-182AAEB4-EE18-48B9-8D18-F3877F23E232
Therapeutic uses of anti-interleukin-6 receptor antibody.
P2860
Q38241714-182AAEB4-EE18-48B9-8D18-F3877F23E232
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38241714-182AAEB4-EE18-48B9-8D18-F3877F23E232
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
660799600e2360f333ef98a9460cbce7ee2d1f51
P2860
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial.